Mometasone furoate/olopatadine hydrochloride

National NHS prescribing (Prescription Cost Analysis) · Drugs acting on the nose

Data updated March 2026

Mometasone furoate/olopatadine hydrochloride was ranked 519th of 1,794 medicines by items in March 2026, with 8,951 items, up 84.9% on a year earlier.

8,951items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£130,483

Net ingredient cost · March 2026

NHSBSA PCA

79,251items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Mometasone furoate/olopatadine hydrochloride: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/mometasone-furoateolopatadine-hydrochloride-1202010z0" width="100%" height="280" style="border:0" loading="lazy" title="Mometasone furoate/olopatadine hydrochloride: NHS prescribing in England — PharmaInsight"></iframe>

Presentations of Mometasone furoate/olopatadine hydrochloride, March 2026
Presentation	Items	Net ingredient cost
Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray	8,951	£130,483

Compare Mometasone furoate/olopatadine hydrochloride with

Other medicines in the same BNF section, by prescribing volume.

Top presentations, March 2026

Compare Mometasone furoate/olopatadine hydrochloride with